NTT Venture Capital (NTTVC) is a venture capital firm that focuses on investing in and supporting innovative technology companies. The firm leverages the strength, stability, and network of the global NTT ecosystem to provide its portfolio companies with strategic resources to accelerate their growth.

NTT Venture Capital

NTTVC is an independent venture capital firm formed in collaboration with NTT. We invest across sectors and partner as early as a founder’s first inspiration through the full expression of their vision. We act with conviction, move fast, and back innovative ideas.

Through our unique partnership-focused strategy and deep industry network, we unlock doors to relationships that help startups reach global scale. Our portfolio companies benefit from unfettered access to the voices that matter – industry experts, customers, entrepreneurs, business leaders, system integrators and service providers. This virtually unlimited data feed offers an incredible level of insight to help startups make better decisions, more quickly. 

NTTVC

NTTVC portfolio company nference was recently named to Newsweek's list of top 50 best healthcare data analytics companies in the US! Becker's Healthcare featured the list of the data analytics-focused digital health companies.

Check it out: https://lnkd.in/eg4Y_Daa

cc: Murali Aravamudan, Venky Soundararajan, Maulik Nanavaty, Mike Koenig, John Halamka, M.D., M.S., Zachi Attia, Andy Danielsen, Mayo Clinic, Mayo Clinic Ventures

#digitalhealth #dataanalytics #healthcare #healthcaredata #newsweek #top50

Excited to see how Pramana is helping transform the digital pathology market and has digitized over 6.5 million glass slides and validated 15 billion images with near-perfect accuracy using Pramana’s in-line quality assurance algorithms. Congratulations and more to come! 

“Our strides in advancing digital pathology, in collaboration with Image Management System partners, have led to the creation of the largest DICOM dataset for digital pathology, paving the way for a future where proprietary image formats are no longer necessary and marking a new era in digital pathology.” – ​​Prasanth Perugupalli, Pramana Chief Product Officer.

Read more about how they are revolutionizing the landscape of pathology labs: https://lnkd.in/eH4FF5zx 

cc: Murali Aravamudan, Prasanth Perugupalli, Mike Koenig, Duke University School of Medicine, Mayo Clinic

#digitalpathology #pathology #AI #GenAI

We're thrilled to support Neysa Networks in their $20m seed funding. Welcome to the NTTVC portfolio! India's first GPU AI cloud and platform-as-a-service company will use the funding to accelerate #generativeAI adoption for enterprises. 

Neysa co-founder and CEO Sharad Sanghi helped fuel the growth of the internet and cloud in India. We are looking forward to working with you again, Sharad Sanghi and Anindya Das.

Read more in Entrepreneur India: https://lnkd.in/eBVPcQ55 

cc: Jishnu B., Avnish Bajaj, BV Jagadeesh, Abhijit Dubey, Charlie Li, NTT DATA, Inc., NTT Global Data Centers and Cloud Infrastructure, India, Vab Goel, Fay Hazaveh Costa 

#AI #generativeAI #enterpriseAI #genAI #funding #seedfunding

A big congratulations to Eko Health on receiving FDA clearance for its Low EF detection AI, developed in collaboration with Mayo Clinic. Low ejection fraction is a primary source of heart failure and can now be detected during routine physical examinations in just 15 seconds using an Eko stethoscope.

“The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with—the stethoscope—can help us prevent hospitalizations and adverse events. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.” - Mayo Clinic Cardiovascular Medicine Department Chair, Paul Friedman, M.D.
 
Read more in Fierce Biotech: https://lnkd.in/gV4Khbcr
 
cc: Connor Landgraf, Jason Bellet, Subbu Venkatraman, Mayo Clinic Ventures, John Halamka, M.D., M.S. 
#fdacleared #digitalhealth #stethoscope #ai #healthtech

COM:NTTVC

NTT Venture Capital